Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty (Q44550200)

4 December 2017

Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty (English)

1 reference

4 December 2017

0 references

Katsuyuki Yamaguchi

1

1 reference

4 December 2017

Kensaku Masuhara

2

1 reference

4 December 2017

Satoshi Yamasaki

3

1 reference

4 December 2017

Tsuyoshi Nakai

4

1 reference

4 December 2017

Takeshi Fuji

5

1 reference

4 December 2017

1 July 2003

1 reference

4 December 2017

1 reference

4 December 2017

33

1 reference

4 December 2017

1

1 reference

4 December 2017

144-149

1 reference

Charnley total hip arthroplasty with cement. Minimum twenty-five-year follow-up

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

The porous-coated anatomic total hip prosthesis, inserted without cement. A prospective study with a minimum of ten years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

The Metal-Cancellous Cementless Lübeck total hip arthroplasty. Five-to-nine-year results

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Cementless prosthesis of the hip joint with "spongy metal" surface. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Spongy metal Lübeck hip prostheses for osteoarthritis secondary to hip dysplasia. A 2-6-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

The effect of positioning on dual energy X-ray bone densitometry of the proximal femur

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Evaluation of periprosthetic bone using dual-energy x-ray absorptiometry: precision of the method and effect of operation on bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

A prospective study of proximal femur bone mass following cemented and uncemented hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Longitudinal evaluation of time related bone remodeling after cementless total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Periprosthetic bone density around fully hydroxyapatite coated femoral stem

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Maintenance of proximal bone mass with an uncemented femoral stem analysis with dual-energy x-ray absorptiometry

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

Evaluation of periprosthetic bone-remodeling after cementless total hip arthroplasty. The influence of the extent of porous coating

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900085-1

7 January 2021

10.1016/S8756-3282(03)00085-1

Identifiers

DOI

1 reference

release_lwufoxpl3zd5jctreomovnxtu4

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lwufoxpl3zd5jctreomovnxtu4

24 November 2022

mapped directly with Wikidata item

1 reference